12 Panel Drug Test Dip - Identify Diagnostics CLIA Waived

Identify Diagnostics 12 Panel Drug Test Dip Card

The current expiration date for this drug test dip is on or better than: DECEMBER 31, 2025

Availability:
Ships same day if by 3pm EST. Signature required delivery.

- CLIA Waived
- FDA 510(K) Cleared
- Over The Counter OTC Cleared
- Purchase in bulk or small quantities to meet your specific volume needs
- Choose from dip pack sizes of: 25, 50, 75, 100, 125, 150, 175, 200, or 250 dips.
- Join our flexible auto-ship program to help make reordering easy
- For larger volume pricing please call 727-744-2967

Drugs Tested:
AMP - Amphetamines 1000 ng/mL
BAR - Barbiturates 300 ng/mL
BUP - Buprenorphine 10 ng/ml
BZO - Benzodiazepines 300 ng/mL
COC - Cocaine 300 ng/mL
MDMA - Ecstasy 500 ng/mL
MET - Methamphetamines 1000 ng/mL
MOP - Opiates / Morphine 300 ng/mL (Same as OPI300)
MTD - Methadone 300 ng/mL
OXY - Oxycodone 100 ng/mL
PCP - Phencyclidine 25 ng/ml
THC - Marijuana 50 ng/mL

Description:
This 12 panel drug test dip is a lateral flow chromatographic Immunoassay for the qualitative detection of multiple drugs and drug metabolites in human urine.  

For the Identify Diagnostics drug test dip card package insert CLIA waiver #1 please click the icon below:


For the Identify Diagnostics drug test dip card package insert CLIA waiver #2 please click the icon below:


The increasing demand for swift and accurate drug testing solutions has given rise to advanced products like the Identify Diagnostics 12 Panel Drug Test Dip Card. Whether it's for employment screenings, periodic checks, or clinical purposes, this product offers a convenient and reliable way to perform multi-drug testing. Let’s delve deeper into its specifications and benefits.

Features:

12 Panel Testing: This drug test dip card can screen for up to 12 different drugs simultaneously. The screened substances are: AMP - Amphetamines 1000 ng/mL, BAR - Barbiturates 300 ng/mL, BUP - Buprenorphine 10 ng/ml, BZO - Benzodiazepines 300 ng/mL, COC - Cocaine 300 ng/mL, MDMA - Ecstasy 500 ng/mL, MET - Methamphetamines 1000 ng/mL, MOP - Opiates / Morphine 300 ng/mL (Same as OPI300), MTD - Methadone 300 ng/mL, OXY Oxycodone 100 ng/mL, PCP - Phencyclidine 25 ng/ml, THC - Marijuana 50 ng/mL. Each panel corresponds to a specific drug or drug class, allowing for broad-spectrum testing.

Rapid Results: One of the major advantages of the Identify Diagnostics Dip Card is its ability to provide results in just 5 minutes. This swift turnaround is crucial for situations that require immediate action or decision-making based on the test results.

CLIA Waived: The term 'CLIA waived' indicates that the test meets specific criteria set by the Clinical Laboratory Improvement Amendments (CLIA). These criteria ensure the test is simple and carries a low risk of producing an incorrect result. Thus, CLIA-waived tests can be used in more diverse settings, including physician’s offices, clinics, and other non-laboratory locations.

Ease of Use: The dip card format allows for straightforward and hassle-free testing. Simply dip the test strip into a urine sample for a specified amount of time and then read the results.

Accuracy: Identify Diagnostics is renowned for producing reliable and accurate testing products. With the 12 Panel Drug Test Dip Card, users can be assured of its precision.

Benefits:

Cost-Effective: Compared to laboratory tests or some electronic drug testing devices, dip cards tend to be more cost-effective, making them a preferred choice for bulk or frequent testing.

Flexibility: Because of its CLIA-waived status, the test can be administered in various settings, making it versatile for diverse scenarios.

Quick Decision Making: Rapid results mean that employers, clinicians, or other stakeholders can make decisions promptly, be it for employment decisions, clinical interventions, or other purposes.

Discreet: The compact design of the dip card makes it discreet and easy to store or transport, allowing for confidential testing when needed.

Reduces Chances of Tampering: The direct dip method can reduce the chances of sample tampering, thus ensuring more reliable results.

In all, the Identify Diagnostics 12 Panel Drug Test Dip Card offers an effective and efficient solution for multi-drug screening. Its quick results, accuracy, and CLIA-waived status make it a top choice for various stakeholders in the drug testing ecosystem.